THE TGA is undertaking a safety review of the drug Diane-35 and its generics following an announcement that France will soon suspend its marketing authorisation. Diane-35, an anti-androgenic progestogen-oestrogen combination, is approved for treating androgenisation in women including severe acne and hirsutism. It is also an effective oral contraceptive in these patients although the TGA […]